Article Highlights
Less than a year after launching in Canada, mylife Loop has gained approval for both iPhone users and Abbott's FreeStyle Libre 3 Plus sensor. The expansion reflects ongoing collaboration between mylife Diabetes Care, CamDiab, and Abbott in response to feedback from people with type 1 diabetes and healthcare professionals. Here's what the expanded compatibility means for Canadians managing type 1 diabetes.
mylife Loop is now compatible with two CGM systems:
- Dexcom G6
- FreeStyle Libre 3 Plus
The system also now works with iPhone in addition to Android devices. mylife Loop is the first AID system approved for use with Abbott's most recent sensor.
Read the official press release on Canada Newswire.
mylife Loop is an automated insulin delivery (AID) system that combines:
- mylife YpsoPump insulin pump
- mylife CamAPS FX app and algorithm (developed by CamDiab)
- Compatible continuous glucose monitoring system
The smartphone-based system uses adaptive technology to automatically adjust insulin delivery based on real-time glucose readings. This is designed to reduce the constant decision-making burden of managing type 1 diabetes. Launched in March 2025 on Android with Dexcom G6 compatibility, mylife Loop was Canada's first smartphone-based automated insulin delivery system.
Managing type 1 diabetes involves numerous daily decisions around glucose monitoring, insulin dosing, nutrition, and activity. Compatibility with two CGM systems provides greater flexibility based on individual preferences, insurance coverage, and sensor availability.
According to mylife Diabetescare, the expansion reflects ongoing collaboration between mylife, CamDiab, and Abbott in response to patient and healthcare professional needs.
In Europe, where mylife Loop has been available for more than three years, patient-reported data highlights meaningful outcomes. In the dQ&A survey, users ranked mylife Loop number one among automated insulin delivery systems for reducing the perceived mental burden of diabetes management.
"For people living with type 1 diabetes, daily therapy involves countless decisions. Expanding mylife Loop compatibility reduces that burden and gives people greater confidence and freedom in how they manage their diabetes—every day," said Karina Schneider, general manager of Ypsomed Canada.
Commercial availability will come soon, though specific timing has not been announced. mylife Loop is intended for people with type 1 diabetes and requires appropriate training. Use should be initiated and managed under the guidance of a healthcare professional.
The approval of iPhone and FreeStyle Libre 3 Plus compatibility represents a significant expansion for mylife Loop in Canada. As the only AID system compatible with two CGM platforms, it provides greater flexibility for managing type 1 diabetes. If you're interested in mylife Loop, talk to your healthcare provider about whether it's appropriate for your diabetes management routine.
